|
01 Nov 2010 |
Medicago Receives Regulatory Approval and Commences Phase II Clinical Testing of its Avian Influenza Vaccine
|
|
01 Nov 2010 |
Phase 2b Study Demonstrates GlobeImmune's GI-5005 HCV Therapeutic Vaccine Increases Sustained Virologic Response by 12 Percent in Patients Who Previously Failed Therapy With Standard of Care
|
|
28 Oct 2010 |
Crucell N.V. (CRXL) Halts Vaccine Shipments to Investigate Plant
|
|
28 Oct 2010 |
GlobeImmune Expands GI-5005-02 Phase 2b Trial to Include Additional Treatment Naive IL28B T/T Subjects With Chronic Genotype 1 HCV
|
|
28 Oct 2010 |
ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University Collaboration
|
|
25 Oct 2010 |
Phase III data show that Novartis meningococcal vaccine Menveo(R) demonstrated robust immunogenicity in infants
|
|
25 Oct 2010 |
Intercell Reports Positive Results From Its Phase II Pseudomonas Aeruginosa Investigational Vaccine Study for Certain Hospital-Acquired Infections
|
|
25 Oct 2010 |
Sanofi Pasteur Presents Phase III Data on Intradermal Microinjection of Influenza Vaccine
|
|
25 Oct 2010 |
Positive Results From LigoCyte's Norovirus Vaccine Challenge Study Presented at IDSA Annual Meeting
|
|
25 Oct 2010 |
Inviragen Initiates DENVax Phase 1 Clinical Testing in Colombia
|
|
25 Oct 2010 |
Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R)
|
|
25 Oct 2010 |
Following Positive Phase II Data, Sanofi Pasteur to Conduct Phase III Trials of Quadrivalent Influenza Virus Vaccine
|
|
22 Oct 2010 |
European regulator backs nasal spray vaccine FLUENZ for the prevention of seasonal influenza in children
|
|
22 Oct 2010 |
Dynavax Technologies Corporation (DVAX)'s HEPLISAV Demonstrates Superior Seroprotection in Diabetics Compared to Engerix-B
|
|
22 Oct 2010 |
Novartis Phase III study indicates MF59(R) adjuvanted influenza vaccine, Fluad(R), is 75 percent more efficacious than studied non-adjuvanted vaccines in young children
|
|
21 Oct 2010 |
Advaxis Completes Recruitment of First 11 Patients in US Cervical Dysplasia Study
|
|
19 Oct 2010 |
MannKind Announces Initiation of Phase 2 Trial of Cancer Vaccine for Advanced Melanoma
|
|
13 Oct 2010 |
Bavarian Nordic Receives NIH Grant to Investigate the Potential of an MVA-BN(R) Based Vaccine Against Ebola and Marburg Viruses
|
|
13 Oct 2010 |
Medicago and PATH collaborate on broad coverage influenza vaccines for the developing world
|
|
11 Oct 2010 |
BiondVax Begins Phase IIa Study for Universal Flu Vaccine
|
|
07 Oct 2010 |
Synthetic Genomics Inc. and J. Craig Venter Institute Form New Company, Synthetic Genomics Vaccines Inc. (SGVI), to Develop Next Generation Vaccines
|
|
07 Oct 2010 |
Vical to Manufacture DNA Vaccines for Advanced Development by HIV Consortium
|
|
05 Oct 2010 |
Immunovaccine and IRX Therapeutics Collaborate on Cancer Immunotherapies
|
|
05 Oct 2010 |
CureVac presents convincing data from the first ever Phase I/IIa clinical study with a mRNA based vaccine
|
|
05 Oct 2010 |
Liquidia Technologies Initiates Phase 1 Trial of Lead Vaccine Candidate
|
